Eribulin Mesylate

Eribulin Mesylate (1-100 nM; 72 h) inhibits cells proliferation of LM8 and Dunn cells. Eribulin Mesylate (10-50 nM; 12-72 h) increases early apoptosis significantly in LM8 cells. Eribulin Mesylate (10-50 nM; 12-72 h) induces G2/M arrest by 12 h treatment with at the dose of 50 nM, but not by long-term treatment (72 h) with 10 nM in LM8 cells. Eribulin Mesylate (1-10 nM; 16 h) induces morphological change and suppresses cell migration in a low concentration in LM8 cells.^{<a class="sref" href="#s_ref">[2]</a>}

LM8 cells and  Dunn cells are incubated with 0 nM, 10 nM, or 50 nM eribulin Mesylate for 12 h, 24 h, 48 h, or 72 h. And then cell proliferation, cell cycle and apoptosis are detected by flow cytometry analysis and immunofluorescence.

Eribulin Mesylate reduces primary tumor growth and lung metastasis of osteosarcoma in mice.^{<a class="sref" href="#s_ref">[2]</a>}